A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 2.79 EUR 0.36% Market Closed
Market Cap: 212.1m EUR

Intrinsic Value

The intrinsic value of one ATRY stock under the Base Case scenario is 4.82 EUR. Compared to the current market price of 2.79 EUR, Atrys Health SA is Undervalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATRY Intrinsic Value
4.82 EUR
Undervaluation 42%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Atrys Health SA

What is Valuation History?
Compare ATRY to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ATRY?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Atrys Health SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Atrys Health SA

Current Assets 89.2m
Cash & Short-Term Investments 29.3m
Receivables 55.4m
Other Current Assets 4.5m
Non-Current Assets 495m
Long-Term Investments 3.2m
PP&E 58.2m
Intangibles 424.1m
Other Non-Current Assets 9.6m
Efficiency

Free Cash Flow Analysis
Atrys Health SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Atrys Health SA

Revenue
212.7m EUR
Cost of Revenue
-67.4m EUR
Gross Profit
145.4m EUR
Operating Expenses
-137.7m EUR
Operating Income
7.7m EUR
Other Expenses
-39.5m EUR
Net Income
-31.8m EUR
Fundamental Scores

ATRY Profitability Score
Profitability Due Diligence

Atrys Health SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
ROIC is Increasing
37/100
Profitability
Score

Atrys Health SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

ATRY Solvency Score
Solvency Due Diligence

Atrys Health SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
28/100
Solvency
Score

Atrys Health SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATRY Price Targets Summary
Atrys Health SA

Wall Street analysts forecast ATRY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRY is 6.17 EUR with a low forecast of 5.66 EUR and a high forecast of 6.83 EUR.

Lowest
Price Target
5.66 EUR
103% Upside
Average
Price Target
6.17 EUR
121% Upside
Highest
Price Target
6.83 EUR
145% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Atrys Health SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ATRY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ATRY stock?

The intrinsic value of one ATRY stock under the Base Case scenario is 4.82 EUR.

Is ATRY stock undervalued or overvalued?

Compared to the current market price of 2.79 EUR, Atrys Health SA is Undervalued by 42%.

Back to Top